Clinical Trial Update: Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating acute effects of preladenant (SCH 420814) on dyskinesia and parkinsonism in levodopa-treated participants with Parkinson disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• preladenant (preladenant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-07-21